Key result
In individuals without overt autoimmune disease, a rheumatoid factor concentration ≥100 IU/mL was strongly associated with an increased risk of DVT over up to 32 years of follow-up (HR 3.1).
Why the study?
Does increased rheumatoid factor concentration increase the risk of incident DVT in individuals without overt autoimmune disease?
Does increased rheumatoid factor concentration increase the risk of incident DVT in individuals without overt autoimmune disease?
Hazard Ratio: 3.1
Authors
No takes yet. Share an insight, caveat, or question.
Increased concentrations of rheumatoid factor are strongly associated with an increased risk of incident DVT in individuals without overt autoimmune disease, supporting the hypothesis that venous thromboembolism is a chronic inflammatory disease.
Piazza et al. (2014) conducted an editorial in Venous thromboembolism (VTE) (n=54,000). Rheumatoid factor concentration ≥100 IU/mL vs. Rheumatoid factor concentration ≤100 IU/mL was evaluated on Deep vein thrombosis (DVT) (HR 3.1). In individuals without overt autoimmune disease, a rheumatoid factor concentration ≥100 IU/mL was strongly associated with an increased risk of DVT over up to 32 years of follow-up (HR 3.1).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: